最新ニュース MSP Recovery (NASDAQ:LIFW) 株価情報

MSP Recovery

MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery Inc

JP Morgan analyst Detlef Winckelmann maintains Smurfit WestRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>) with a Overweight and raises the price target from $65 to $69.

News

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Smurfit WestRock, Raises Price Target to $69

Whales with a lot of money to spend have taken a noticeably bearish stance on Moderna.
Looking at options history for Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) we detected 11 trades.
If we consider the specifics of each trade, it is accurate to state that 18% of the investors opened trades with bullish expectations and 63% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $1,196,435 and 2, calls, for a total amount of $1,384,310.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $22.5 and $105.0 for Moderna, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 3135.88 with a total volume of 4,381.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $22.5 to $105.0 over the last 30 days.
<h3>Moderna Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732895188_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$5.05</td>
<td>$4.8</td>
<td>$4.85</td>
<td>$50.00</td>
<td>$1.3M</td>
<td>1.5K</td>
<td>2.7K</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$5.5</td>
<td>$4.95</td>
<td>$5.25</td>
<td>$30.00</td>
<td>$446.2K</td>
<td>1.4K</td>
<td>852</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$13.25</td>
<td>$11.4</td>
<td>$13.25</td>
<td>$55.00</td>
<td>$331.2K</td>
<td>4.7K</td>
<td>10</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$12.05</td>
<td>$11.85</td>
<td>$11.85</td>
<td>$50.00</td>
<td>$141.0K</td>
<td>4.0K</td>
<td>120</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$11.2</td>
<td>$11.15</td>
<td>$11.2</td>
<td>$50.00</td>
<td>$76.1K</td>
<td>112</td>
<td>1</td>
</tr>
</tbody>
</table>

<h3>About Moderna</h3>
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Moderna</h3>
<ul>
<li>Currently trading with a volume of 1,119,525, the MRNA's price is up by 0.14%, now at $43.45. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 83 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

MRNA

Moderna's Options: A Look at What the Big Money is Thinking

Whales with a lot of money to spend have taken a noticeably bullish stance on Hewlett Packard.
Looking at options history for Hewlett Packard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 70% of the investors opened trades with bullish expectations and 20% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $61,806 and 8, calls, for a total amount of $470,807.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $18.0 to $22.0 for Hewlett Packard during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Hewlett Packard's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Hewlett Packard's significant trades, within a strike price range of $18.0 to $22.0, over the past month.
<h3>Hewlett Packard Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732895183_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HPE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$3.4</td>
<td>$3.2</td>
<td>$3.3</td>
<td>$18.00</td>
<td>$132.0K</td>
<td>1.7K</td>
<td>400</td>
</tr>
<tr>
<td>HPE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$5.1</td>
<td>$4.8</td>
<td>$5.04</td>
<td>$20.00</td>
<td>$94.7K</td>
<td>135</td>
<td>200</td>
</tr>
<tr>
<td>HPE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$0.95</td>
<td>$0.85</td>
<td>$0.95</td>
<td>$21.50</td>
<td>$70.8K</td>
<td>250</td>
<td>3.0K</td>
</tr>
<tr>
<td>HPE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$0.95</td>
<td>$0.85</td>
<td>$0.95</td>
<td>$21.50</td>
<td>$49.6K</td>
<td>250</td>
<td>2.4K</td>
</tr>
<tr>
<td>HPE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$0.95</td>
<td>$0.9</td>
<td>$0.95</td>
<td>$21.50</td>
<td>$33.4K</td>
<td>250</td>
<td>990</td>
</tr>
</tbody>
</table>

<h3>About Hewlett Packard</h3>
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure. It uses a primarily outsourced manufacturing model and employs 60,000 people worldwide.
Having examined the options trading patterns of Hewlett Packard, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Hewlett Packard</h3>
<ul>
<li>Trading volume stands at 1,788,029, with HPE's price up by 2.0%, positioned at $21.21.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 6 days.</li>
</ul>
<h3>Expert Opinions on Hewlett Packard</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $26.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Citigroup persists with their Neutral rating on Hewlett Packard, maintaining a target price of $23. 
&#x2A; In a positive move, an analyst from Raymond James has upgraded their rating to Strong Buy and adjusted the price target to $29. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Hewlett Packard options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Unpacking the Latest Options Trading Trends in Hewlett Packard

Deep-pocketed investors have adopted a bullish approach towards Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CVNA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Carvana. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 60% leaning bullish and 40% bearish. Among these notable options, 5 are puts, totaling $295,000, and 5 are calls, amounting to $205,854.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $240.0 and $305.0 for Carvana, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Carvana's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Carvana's substantial trades, within a strike price spectrum from $240.0 to $305.0 over the preceding 30 days.
<h3>Carvana Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732895178_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$43.45</td>
<td>$42.2</td>
<td>$43.45</td>
<td>$280.00</td>
<td>$91.2K</td>
<td align="right">146</td>
<td>21</td>
</tr>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$43.15</td>
<td>$42.35</td>
<td>$43.15</td>
<td>$280.00</td>
<td>$81.9K</td>
<td align="right">146</td>
<td>40</td>
</tr>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$5.85</td>
<td>$5.0</td>
<td>$5.0</td>
<td>$260.00</td>
<td>$50.5K</td>
<td align="right">386</td>
<td>108</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$35.9</td>
<td>$32.9</td>
<td>$35.2</td>
<td>$300.00</td>
<td>$49.2K</td>
<td align="right">83</td>
<td>14</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$0.49</td>
<td>$0.31</td>
<td>$0.49</td>
<td>$290.00</td>
<td>$48.5K</td>
<td align="right">115</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About Carvana</h3>
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.
In light of the recent options history for Carvana, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Carvana's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 514,090, the CVNA's price is up by 2.31%, now at $260.86. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 83 days.</li>
</ul>
<h3>What Analysts Are Saying About Carvana</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $269.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from JMP Securities persists with their Market Outperform rating on Carvana, maintaining a target price of $320. 
&#x2A; An analyst from Morgan Stanley upgraded its action to Equal-Weight with a price target of $260. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Carvana, which currently sits at a price target of $300. 
&#x2A; An analyst from Baird has decided to maintain their Neutral rating on Carvana, which currently sits at a price target of $240. 
&#x2A; An analyst from Piper Sandler persists with their Neutral rating on Carvana, maintaining a target price of $225. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Carvana with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

CVNA

Smart Money Is Betting Big In CVNA Options

Canadian cannabis producer Entourage Health Corp. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#TSXV">ENTG</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ETRGF#OTCQX">ETRGF</a>) (FSE: 4WE) announced on Friday its third quarter financial results for the three months ended Sept. 30, 2024.
The company reported an 8% year-over-year increase to CA$9.5 million ($6.8 million) in net revenue for the period. Sequentially, net revenue <a href="https://www.benzinga.com/markets/cannabis/24/08/40577400/entourage-cannabis-co-s-q2-revenue-drops-nearly-9-yoy-ceo-optimistic-about-future-opportunities">increased by 2.1%</a>
George Scorsis, the company's CEO and chair, said the revenue growth is a result of a strategic shift into different markets. The move allowed the company to "diversify and tap into new opportunities," Scorsis said.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/05/39037667/entourage-health-cannabis-reports-9-yoy-increase-in-q1-revenue-positive-ebitda-and-substantial-g">Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And &#8216;Substantial Growth&#8217;</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Q3 2024 Financial Results</h3>
<ul>
<li>Gross profit was CA$2.9 million, up from CA$2.4 million in the prior year's period.</li>
<li>Gross margin improved to 30%, up from 27% in the same period last year, driven by enhanced operational efficiencies and automation.</li>
<li>Net loss and comprehensive loss dropped to CA$8.4 million year-over-year from nearly CA$10 million.</li>
<li>EBITDA was a loss of CA$1 million, representing a 70% improvement compared to a loss of CA$3.4 million in the third quarter of fiscal 2023.</li>
<li>Selling, general and administrative expenses were reduced by 32%, reflecting savings from restructuring and discontinued activities in 2023.</li>
</ul>
<h3 class="wp-block-heading">What's Next</h3>
&#8220;With the holidays approaching, we are excited to introduce several highly anticipated products, demonstrating our commitment to delivering meaningful and timely offerings,&#8221; Scorsis said. &#8220;As the cannabis industry stabilizes, our team's creativity and operational focus on optimizing the business will position us as a market leader." 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/04/38525232/cannabis-co-entourage-health-reports-126-yoy-increase-in-2023-gross-profit-cuts-losses-significa">Cannabis Co. Entourage Health Reports 126% YoY Increase In 2023 Gross Profit, Cuts Losses Significantly</a></li>
</ul>
ETRGF Price Action
Entourage's shares traded 18.75% higher at $0.0048 per share at the time of writing on Friday.

Cannabis

Earnings

ETRGF

TSXV:ENTG

Canadian Cannabis Co. Entourage Health Shares Spike On 8% YoY Q3 Revenue Growth, Reduced Losses

A new Senate <a href="https://www.hsgac.senate.gov/wp-content/uploads/2024.11.25-Majority-Staff-Report-The-Skys-the-Limit-The-Rise-of-Junk-Fees-in-American-Travel-1.pdf">report</a> has shed light on just how much money airlines are making off add-ons like seat and <a href="https://www.benzinga.com/markets/equities/24/06/39288640/southwest-airlines-free-bag-policy-under-pressure-after-elliotts-1-9b-stake">baggage fees</a>. And it&#8217;s a lot: $12.4 billion from seat selection fees alone between 2018 and 2023. And now, lawmakers and the Biden administration are saying enough is enough.
Sen.<a href="https://www.benzinga.com/news/23/12/36323074/tesla-executive-says-senator-blumenthals-autopilot-claims-misinformed-invites-meeting-with-safety-te"> Richard Blumenthal</a>, who chairs the Senate&#8217;s Permanent Subcommittee on Investigations, recently revealed the findings. Blumenthal said that airlines have been exploiting passengers with what he calls &#8220;junk fees,&#8221; like extra charges for picking your seat – whether it's just for a standard aisle or window spot or the more spacious, extra legroom seats.&nbsp;
Don't Miss:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
<li>It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
</ul>
These fees have become a huge source of income for big airlines like American, Delta, United, Frontier and Spirit, bringing in billions. At the same time, passengers deal with higher prices and a more confusing booking experience.
Seat fees increased substantially over the five years. Per the report, Frontier Airlines, for example, raised the price of its most expensive extra legroom seat from $50 in 2018 to $141 in 2023. Spirit Airlines similarly escalated its maximum seat fee for extra legroom from $71 in 2018 to $299 in 2023. Spirit&#8217;s Big Front Seats, the airline&#8217;s most premium seating option, saw an even bigger rise, going from $140 to $899 over the same time frame.
Blumenthal argues that these charges aren't tied to any real cost to the airline. The report found that the airlines couldn't clearly show what it costs them to offer seat assignments. This suggests that the prices aren&#8217;t based on the service provided but are another way to bump up revenues. And if you&#8217;ve ever booked a flight and faced charges just to make sure you sit next to your kid, you know how frustrating it can be.
See Also: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a>
The Biden administration also addresses these fees, which they see as unfair burdens on travelers. As part of his larger campaign against &#8220;junk fees&#8221; in various sectors, including banks, hotels and other services that tack on additional fees, President Biden has spoken out against these charges. <a href="https://www.benzinga.com/government/24/08/40112052/family-friendly-skies-proposal-aims-to-end-airline-seating-fees-for-parents-with-kids">Families shouldn&#8217;t have to pay more</a> just to sit together, so the administration wants to make flying easier.
The Senate&#8217;s investigation also highlighted other questionable practices. For example, airlines like Frontier and Spirit have been paying gate agents to enforce baggage rules strictly, leading to passengers being charged extra for their bags and sometimes even missing flights because of it. Between 2022 and 2023 alone, these gate agents received around $26 million in commissions for catching passengers out on baggage size, according to the Majority Report.
Trending: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
Airline executives from the major carriers are set to testify at a Senate hearing on Dec. 4 to answer for these practices. The hearing, &#8220;The Sky&#8217;s the Limit – New Revelations About Airline Fees,&#8221; is anticipated to probe the reasons behind the exorbitant prices and whether there is any real basis for them.
The airlines, of course, have defended their actions. As CNBC reports, Airlines for America, a trade group representing the biggest U.S. carriers, pushed back, saying that the Senate report doesn't &#8220;understand the value the highly competitive U.S. airline industry brings to customers and employees.&#8221; They also claim that today&#8217;s more competitive pricing structure makes flying more affordable. However, critics point out that the complexity and rising costs of add-ons like seat fees often make trips <a href="https://www.benzinga.com/markets/equities/24/07/40030510/us-appeals-court-halts-bidens-airline-fee-disclosure-rule-saying-it-will-irreparably-harm-carrie">more expensive than they initially appear</a> when you first see the ticket price.
Read Next:
<ul>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
</ul>

Startups

In 5 Years, Airlines Made $12.4 Billion From Seating Fees Alone. Senate And Biden Admin Say These 'Junk Fees' Must Stop

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>) with a Buy and maintains $11 price target.

Reiteration

CLGN

HC Wainwright & Co. Reiterates Buy on CollPlant Biotechnologies, Maintains $11 Price Target

DA Davidson analyst Linda Bolton Weiser maintains Planet Fitness (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) with a Neutral and raises the price target from $70 to $87.

PLNT

DA Davidson Maintains Neutral on Planet Fitness, Raises Price Target to $87

Laser Photonics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASE#NASDAQ">LASE</a>) launched a research and development initiative to create laser solutions for pharmaceutical tablet drilling, wafer <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42241997/laser-photonics-launches-r-d-initiative-to-accelerate-innovation" rel="noreferrer noopener">scribing, and semiconductor marking</a>.
Laser Photonics is targeting pharmaceuticals, wafers, and semiconductors through its latest R&amp;D initiative. Following its&nbsp;recent acquisition&nbsp;of&nbsp;Control Micro Systems, the company is committing resources to several new engineering projects to continue advancing its newly acquired laser systems.&nbsp;
In pharmaceuticals, the company plans to advance Control Micro Systems&#8217; tablet drilling and marking system for time-release medications.
This Class I automated CO2 laser system includes a custom tablet fixture, fume extraction, and machine vision inspection for quality control, offering an effective anti-counterfeiting solution.
Laser technology for wafer serialization involves marking, scribing, and lapping silicon and related compound wafers.
The company plans to enhance Control Micro Systems' multi-station system, designed for wafers up to 300 mm wide and 300–800 microns thick, featuring robotic wafer positioning.
This technology supports production and tracking for applications such as consumer electronics, solar panels, LEDs, MEMS devices, and optoelectronic components.
Laser Photonics will also advance Control Micro Systems&#8217; semiconductor laser marking system, featuring a high-precision ultraviolet laser and galvanometer scanhead for rapid fiducial recognition.
This system creates small, permanent markings on IC mold compounds and ceramics with minimal heat, preventing damage to components. Integrated machine vision ensures accurate chip positioning and marking alignment.
This week, Laser Photonics opened pre-orders for its upcoming CleanTech Industrial <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42210836/laser-photonics-commences-pre-orders-for-industry-leading-pulsed-laser-cleaning-system" rel="noreferrer noopener">Roughening Laser 3060 (CTIR-3060)</a>.
Price Action: LASE shares are up 0.36% at $5.63 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42244572" target="_blank" rel="noreferrer noopener">Cannabis-Focused RIV Capital Reports 186% YoY Surge In Q3 Revenue Ahead Of Major Merger That Will Cover 25% Of US Population</a></li>
</ul>
Image via Unsplash.

Equities

Small Cap

LASE

From Pills To Wafers: Laser Photonics Unveils R&D Initiative For Anti-Counterfeiting And High-Tech Manufacturing

CLSA analyst Baden Moore initiates coverage on Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) with a Underperform rating.

Initiation

CLSA Initiates Coverage On Newmont with Underperform Rating

Wedbush analyst Daniel Ives reiterates Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) with a Outperform and maintains $300 price target.

AAPL

Wedbush Reiterates Outperform on Apple, Maintains $300 Price Target

WIIM

APVO

Aptevo Therapeutics shares are trading lower after the company announced a 1-for-37 reverse stock split.

Canaccord Genuity analyst George Gianarikas maintains Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) with a Buy and lowers the price target from $37 to $34.

FLNC

Canaccord Genuity Maintains Buy on Fluence Energy, Lowers Price Target to $34

Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares are trading higher<a href="https://www.benzinga.com/movers" target="_blank" rel="noreferrer noopener"> Friday morning.</a>
Tesla China shortened its payment cycle to supply chain partners to just 90 days in 2024, down from 100 days in 2023, according to Grace Tao, Tesla&#8217;s vice president of External Affairs, <a href="https://cnevpost.com/2024/11/28/tesla-china-payment-cycle-to-suppliers-90-days/" target="_blank" rel="noreferrer noopener">reported</a> CnEV Post.
Tao shared the update in a Weibo post, noting that four other unnamed new energy vehicle (NEV) makers still take over 150 days to settle payments.
This improvement is part of Tesla&#8217;s efforts to streamline operations and enhance supplier relationships.
See Also:&nbsp;<a target="_blank" href="https://www.benzinga.com/24/11/42156817/tesla-rivian-settle-battery-tech-theft-dispute-after-nearly-4-years?itm_source=parsely-api" rel="noreferrer noopener">Tesla, Rivian Signal End To 4-Year Legal Battle Over Alleged Trade Secrets Theft</a>
Meanwhile, the EV behemoth revamped its referral program across North America as it races to a <a href="https://www.benzinga.com/news/24/10/41443856/tesla-offers-discounts-of-up-to-4k-on-select-model-3-y-vehicles-as-it-looks-to-avert-1st-ever-declin" target="_blank" rel="noreferrer noopener">delivery target of 515,000 vehicles</a> in the<a href="https://www.benzinga.com/markets/24/11/42207185/tesla-sweetens-referral-program-allowing-customers-to-earn-up-to-10000-as-elon-musks-ev-giant-races-to-500k-q4-delivery-target" target="_blank" rel="noreferrer noopener"> fourth quarter.</a> Tesla&#8217;s updated referral program includes enhanced discounts and rewards, with specific incentives for the Cybertruck.
The company recently started offering unlimited overnight charging via the&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/11/42081589/tesla-electric-offers-unlimited-overnight-charging-for-just-5-a-month-as-ev-giant-races-toward-5" rel="noreferrer noopener">Tesla Electric service</a>, down from $15 a month, aiming to attract more buyers.
This follows&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/10/41443856/tesla-offers-discounts-of-up-to-4k-on-select-model-3-y-vehicles-as-it-looks-to-avert-1st-ever-declin" rel="noreferrer noopener">discounts of up to $4,000</a> on select&nbsp;Model 3 and Model Y&nbsp;vehicles to avoid a decline in annual deliveries.
Despite these efforts,&nbsp;<a href="https://www.benzinga.com/tech/24/11/41894615/tesla-q4-deliveries-expected-to-set-new-records-but-not-enough-to-avoid-yearly-sales-decline-says-researcher" target="_blank" rel="noreferrer noopener">analysts predict</a> that Tesla's fourth-quarter deliveries will set new records but may not prevent a yearly sales decline. The&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41988194/trump-plans-to-erase-ev-tax-credit-analyst-says-its-net-bullish-calls-sell-off-wrong-knee-jerk-reaction" target="_blank" rel="noreferrer noopener">potential removal of the $7,500 EV tax credit</a>&nbsp;by the incoming Trump administration could further affect Tesla's sales, as highlighted by&nbsp;<a href="https://www.benzinga.com/news/global/24/11/41998381/tesla-earnings-will-be-hit-hardest-if-7500-ev-credit-is-cut-warns-gary-black-citing-80-dependence-on-ev-sales-please-do-the-math" target="_blank" rel="noreferrer noopener">Gary Black</a>, who warns of significant earnings impact if the credit is cut.
TSLA Price Action: Tesla shares are trading higher by 2.51% to $341.18 at publication Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/11/42160725/tesla-faces-environmental-violations-as-elon-musks-doge-prepares-for-garbage-collection-of-rules-that-dont-make-sense-report?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Faces Environmental Violations As Elon Musk's ‘DOGE' Prepares For ‘Garbage Collection Of Rules That Don&#8217;t Make Sense</a></li>
</ul>
Photo: Courtesy Tesla

Global

Movers

General

TSLA

Tesla China Shortens Payment Cycle To 90 Days In 2024: Report

Financial giants have made a conspicuous bullish move on ASML Holding. Our analysis of options history for ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) revealed 82 unusual trades.
Delving into the details, we found 57% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 29 were puts, with a value of $2,588,601, and 53 were calls, valued at $4,795,957.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $580.0 to $800.0 for ASML Holding over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of ASML Holding stands at 313.4, with a total volume reaching 6,778.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in ASML Holding, situated within the strike price corridor from $580.0 to $800.0, throughout the last 30 days.
<h3>ASML Holding 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732894317_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ASML</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$87.7</td>
<td>$86.9</td>
<td>$86.9</td>
<td>$760.00</td>
<td>$191.1K</td>
<td align="right">231</td>
<td align="right">22</td>
</tr>
<tr>
<td>ASML</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$86.8</td>
<td>$86.0</td>
<td>$86.0</td>
<td>$760.00</td>
<td>$189.2K</td>
<td align="right">231</td>
<td align="right">66</td>
</tr>
<tr>
<td>ASML</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$86.3</td>
<td>$85.5</td>
<td>$85.5</td>
<td>$750.00</td>
<td>$188.1K</td>
<td align="right">37</td>
<td align="right">66</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$41.2</td>
<td>$40.8</td>
<td>$41.2</td>
<td>$680.00</td>
<td>$168.9K</td>
<td align="right">334</td>
<td align="right">281</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$21.7</td>
<td>$20.9</td>
<td>$21.5</td>
<td>$690.00</td>
<td>$150.5K</td>
<td align="right">347</td>
<td align="right">75</td>
</tr>
</tbody>
</table>

<h3>About ASML Holding</h3>
ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML's main clients are TSMC, Samsung, and Intel.
Following our analysis of the options activities associated with ASML Holding, we pivot to a closer look at the company's own performance.
<h3>ASML Holding's Current Market Status</h3>
<ul>
<li>With a trading volume of 550,696, the price of ASML is up by 3.75%, reaching $695.64.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 61 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for ASML Holding</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $767.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Bernstein persists with their Outperform rating on ASML Holding, maintaining a target price of $767. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for ASML Holding, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ASML

ASML Holding's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bullish stance on Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TSLA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 204 uncommon options trades for Tesla.
This isn't normal.
The overall sentiment of these big-money traders is split between 47% bullish and 38%, bearish.
Out of all of the special options we uncovered, 54 are puts, for a total amount of $3,650,355, and 150 are calls, for a total amount of $11,585,823.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $5.0 to $700.0 for Tesla during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Tesla's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tesla's whale trades within a strike price range from $5.0 to $700.0 in the last 30 days. 
<h3>Tesla Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732894311_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/06/24</td>
<td>$15.75</td>
<td>$15.3</td>
<td>$15.55</td>
<td>$330.00</td>
<td>$262.7K</td>
<td>3.4K</td>
<td>1.3K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$3.05</td>
<td>$3.0</td>
<td>$3.05</td>
<td>$340.00</td>
<td>$171.3K</td>
<td>13.0K</td>
<td>65.1K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/29/24</td>
<td>$5.9</td>
<td>$5.85</td>
<td>$5.85</td>
<td>$335.00</td>
<td>$152.1K</td>
<td>7.8K</td>
<td>13.2K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$12.0</td>
<td>$11.7</td>
<td>$12.0</td>
<td>$330.00</td>
<td>$147.6K</td>
<td>10.8K</td>
<td>6.5K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.65</td>
<td>$2.64</td>
<td>$2.64</td>
<td>$485.00</td>
<td>$131.2K</td>
<td>175</td>
<td>2.7K</td>
</tr>
</tbody>
</table>

<h3>About Tesla</h3>
Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and a robotaxi. Global deliveries in 2023 were a little over 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.
Having examined the options trading patterns of Tesla, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Tesla</h3>
<ul>
<li>With a trading volume of 11,096,249, the price of TSLA is up by 1.86%, reaching $339.07.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 54 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Tesla</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $317.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Wedbush keeps a Outperform rating on Tesla with a target price of $400. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Tesla with a target price of $350. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Tesla, maintaining a target price of $313. 
&#x2A; An analyst from Jefferies persists with their Hold rating on Tesla, maintaining a target price of $300. 
&#x2A; An analyst from UBS persists with their Sell rating on Tesla, maintaining a target price of $226. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Tesla options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

What the Options Market Tells Us About Tesla

Financial giants have made a conspicuous bullish move on Symbotic. Our analysis of options history for Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) revealed 8 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $210,224, and 4 were calls, valued at $196,187.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $22.0 to $37.5 for Symbotic over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Symbotic's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Symbotic's whale activity within a strike price range from $22.0 to $37.5 in the last 30 days. 
<h3>Symbotic Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732894306_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SYM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$0.95</td>
<td>$0.9</td>
<td>$0.95</td>
<td>$22.00</td>
<td>$101.3K</td>
<td>108</td>
<td>1.0K</td>
</tr>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.4</td>
<td>$3.1</td>
<td>$3.0</td>
<td>$25.00</td>
<td>$61.5K</td>
<td>1.3K</td>
<td>243</td>
</tr>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$7.6</td>
<td>$7.1</td>
<td>$7.25</td>
<td>$22.50</td>
<td>$53.6K</td>
<td>463</td>
<td>12</td>
</tr>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.75</td>
<td>$1.5</td>
<td>$1.5</td>
<td>$30.00</td>
<td>$45.0K</td>
<td>2.4K</td>
<td>294</td>
</tr>
<tr>
<td>SYM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$5.5</td>
<td>$5.3</td>
<td>$5.4</td>
<td>$27.50</td>
<td>$41.0K</td>
<td>365</td>
<td>115</td>
</tr>
</tbody>
</table>

<h3>About Symbotic</h3>
Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys innovative, end-to-end technology solutions that dramatically improve supply chain operations. Symbotic also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.
Having examined the options trading patterns of Symbotic, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Symbotic</h3>
<ul>
<li>With a trading volume of 3,288,012, the price of SYM is up by 6.44%, reaching $25.54.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 66 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Symbotic</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $43.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Needham continues to hold a Buy rating for Symbotic, targeting a price of $46. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $60. 
&#x2A; Consistent in their evaluation, an analyst from BWS Financial keeps a Sell rating on Symbotic with a target price of $10. 
&#x2A; Consistent in their evaluation, an analyst from Northland Capital Markets keeps a Outperform rating on Symbotic with a target price of $53. 
&#x2A; Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Symbotic with a target price of $48. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Symbotic, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Symbotic Unusual Options Activity

Wedbush analyst Yun Zhong assumes Passage Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) with a Outperform rating and announces Price Target of $4.

PASG

Wedbush Assumes Passage Bio at Outperform, Announces Price Target of $4

BGM Group shares are trading higher after the company announced its acquisition of the intelligent platform of AIX Inc., valued at approximately $140 million.

Developmental-stage biopharmaceutical company Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) shares are<a href="https://www.benzinga.com/movers" target="_blank" rel="noreferrer noopener"> trading higher on Friday</a>.
The company has announced a collaboration with Kymanox to develop a specialized subcutaneous insertion device for SP-26, its ketamine-loaded implant aimed at treating <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42243217/silo-pharma-enters-joint-development-agreement-for-sp-26-ketamine-implant-device-targeting-pain-ma" rel="noreferrer noopener">fibromyalgia and chronic pain</a>.
The agreement includes a proof-of-concept design phase followed by prototype testing to determine the optimal tissue insertion depth.
Silo Pharma&#8217;s CEO, Eric Weisblum, highlighted that previous trials have confirmed the implant&#8217;s optimal formulation, and the focus now shifts to refining the insertion device for preclinical studies.
&#8220;Now we are advancing this program to develop a novel insertion device that is intended to be tested in continuing preclinical studies,&#8221; Weisblum added.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42244387/nvidia-lam-reasearch-applied-materials-stocks-gain-as-biden-government-eyes-softer-semiconductor-sanctions-against-china" rel="noreferrer noopener">Nvidia, Chip Stocks Gain On Reports Of Softer China Sanctions</a>
If clinically successful, SP-26 could qualify for the FDA&#8217;s streamlined 505(b)(2) regulatory pathway for drug approval, the company said.
SP-26 is designed with the goal of meeting FDA safety standards for at-home use. In addition to the SP-26 project, Kymanox also serves as Silo&#8217;s regulatory partner for SPC-15, a treatment for stress-related disorders like PTSD.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, SILO stock has lost over 39% in the past year.
Price Action: SILO shares are trading higher by 6.68% to $0.9601 at last check Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42198109/nvidia-blackwell-supplier-vishay-intertechnology-likey-to-see-upside-courtesy-of-ai-frenzy-analyst" target="_blank" rel="noreferrer noopener">Nvidia Blackwell Supplier Vishay Intertechnology Likely To See Upside Courtesy Of AI Frenzy: Analyst</a></li>
</ul>
Photo via Shutterstock.

SILO

Why Is Silo Pharma Stock Gaining Today?

MSP Recovery GAAP EPS of -$1.26, revenue of $6M

MSP Recovery, Inc. (LIFW) Q1 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Wednesday with our breakdown of all the biggest news affecting shares this morning.



Moving stocks this morning are merger agreements, eaernings reports, late filings notices and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Vivopower (NASDAQ:<a href="https://investorplace.com/stock-quotes/vvpr-stock-quote/">VVPR</a>) stock is rocketing more than 75% as its Tembo subsidiary <a href="https://www.nasdaq.com/press-release/vivopowers-tembo-confirms-heads-agreement-exclusivity-extension-us-838m-merger-ccts">prepares for a merger</a>.</li>



<li>Zoomcar (NASDAQ:<a href="https://investorplace.com/stock-quotes/zcar-stock-quote/">ZCAR</a>) shares are soaring over 33% with the <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318428597&amp;type=PDF&amp;symbol=ZCAR&amp;cdn=815824f42d62c01bbe441848d3eae09a&amp;companyName=Zoomcar+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-07-01">departure of its CEO</a> and a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318432468&amp;type=PDF&amp;symbol=ZCAR&amp;cdn=dc00ab75a334038308b226d996648882&amp;companyName=Zoomcar+Holdings+Inc.&amp;formType=NT+10-K&amp;formDescription=Notification+of+inability+to+timely+file+Form+10-K+405%2C+10-K%2C+10-KSB+405%2C+10-KSB%2C+10-KT%2C+or+10-KT405&amp;dateFiled=2024-07-02">late filing notice</a>.</li>



<li>Maxeon Solar Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/maxn-stock-quote/">MAXN</a>) stock is surging more than 27% alongside heavy pre-market trading.</li>



<li>Caravelle (NASDAQ:<a href="https://investorplace.com/stock-quotes/caco-stock-quote/">CACO</a>) shares are gaining over 24% without any clear news this morning.</li>



<li>CureVac (NASDAQ:<a href="https://investorplace.com/stock-quotes/cvac-stock-quote/">CVAC</a>) stock is increasing more than 23% on <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-buys-full-rights-make-covid-influenza-vaccines-curevac-2024-07-03/">news of a vaccine sale</a>.</li>



<li>DouYu (NASDAQ:<a href="https://investorplace.com/stock-quotes/doyu-stock-quote/">DOYU</a>) shares are rising over 22% after announcing a <a href="https://www.nasdaq.com/press-release/douyu-international-holdings-limited-announces-special-cash-dividend-2024-07-03">special cash dividend</a>.</li>



<li>MSP Recovery (NASDAQ:<a href="https://investorplace.com/stock-quotes/lifw-stock-quote/">LIFW</a>) stock is heading more than 20% higher despite a lack of news this morning.</li>



<li>Koss (NASDAQ:<a href="https://investorplace.com/stock-quotes/koss-stock-quote/">KOSS</a>) shares are climbing over 19% without any obvious news to report.</li>



<li>Scilex (NASDAQ:<a href="https://investorplace.com/stock-quotes/sclx-stock-quote/">SCLX</a>) stock is jumping more than 18% as subsidiary Semnur Pharmaceuticals <a href="https://www.globenewswire.com/news-release/2024/07/02/2907841/0/en/Semnur-Pharmaceuticals-Inc-a-Wholly-Owned-Subsidiary-of-Scilex-Holding-Company-and-Denali-Capital-Acquisition-Corp-Nasdaq-DECA-Enter-into-a-Letter-of-Intent-for-a-Proposed-Business.html">enters a merger agreement</a>.</li>



<li>U Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucar-stock-quote/">UCAR</a>) shares are up close to 18% after <a href="https://www.nasdaq.com/press-release/u-power-expands-global-footprint-strategic-move-thai-market-2024-07-03">announcing an expansion into Thailand</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Shapeways (NASDAQ:<a href="https://investorplace.com/stock-quotes/shpw-stock-quote/">SHPW</a>) stock is plummeting over 39% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318434959&amp;type=PDF&amp;symbol=SHPW&amp;cdn=ad248035b57b9d6b5efbd20955a6955d&amp;companyName=Shapeways+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-07-03">filing for Chapter 7 bankruptcy</a>.</li>



<li>First Foundation (NYSE:<a href="https://investorplace.com/stock-quotes/ffwm-stock-quote/">FFWM</a>) shares are diving more than 27% with the release of its <a href="https://www.nasdaq.com/press-release/first-foundation-inc-announces-second-quarter-2024-earnings-conference-call-details">Q2 earnings report</a>.</li>



<li>Upexi (NASDAQ:<a href="https://investorplace.com/stock-quotes/upxi-stock-quote/">UPXI</a>) stock is taking an over 13% beating <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318432555&amp;type=PDF&amp;symbol=UPXI&amp;cdn=9b1bbc06760a8be879bdd983cb8a3296&amp;companyName=Upexi+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-07-02">with a late filing</a>.</li>



<li>Eshallgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHGO#NASDAQ">EHGO</a>) shares are tumbling more than 13% after <a href="https://www.nasdaq.com/press-release/eshallgo-inc-announces-pricing-initial-public-offering-2024-07-01">pricing a public offering</a>.</li>



<li>Universe Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/upc-stock-quote/">UPC</a>) stock is sliding over 12% this morning.</li>



<li>Noah (NYSE:<a href="https://investorplace.com/stock-quotes/noah-stock-quote/">NOAH</a>) shares are falling more than 10% without any apparent news today.</li>



<li>Sunrise New Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/epow-stock-quote/">EPOW</a>) stock is dropping over 9% this morning.</li>



<li>Ocean Power Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/optt-stock-quote/">OPTT</a>) shares are decreasing more than 9% <a href="https://investorplace.com/2024/07/why-is-ocean-power-optt-stock-up-80-today/">after a rally yesterday</a>.</li>



<li>Forge Global (NYSE:<a href="https://investorplace.com/stock-quotes/frge-stock-quote/">FRGE</a>) stock is slipping nearly 9% on Wednesday.</li>



<li>Golden Heaven (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdhg-stock-quote/">GDHG</a>) shares close out our pre-market stock movers down over 8% after a Tuesday rally.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-july-3rd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
MSP Recovery (NASDAQ:<a href="https://investorplace.com/stock-quotes/lifw-stock-quote/">LIFW</a>) just reported results for the second quarter of 2024.<ul><li>MSP Recovery reported earnings per share of -78 cents.</li><li>The company reported revenue of $337,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/lifw-stock-earnings-msp-recovery-for-q2-of-2024/">LIFW Stock Earnings: MSP Recovery Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

LIFW Stock Earnings: MSP Recovery Reported Results for Q2 2024

MSP Recovery (LIFW), doing business as LifeWallet, announced new settlements totaling more than $5.9M, continued progress in recoveries on owned cl...

MSP Recovery announces new settlements totaling more than $5.9M

MSP Recovery (LIFW), Inc. d/b/a LifeWallet will affect a reverse stock split of its Class A common stock at a reverse stock split ratio of 1-for-25...

LifeWallet announces 1-for-25 reverse stock split

MSP Recovery announces 1-for-25 reverse stock split to regain Nasdaq compliance

MSP Recovery GAAP EPS of -$1.26

19:50 EST MSP Recovery (LIFW) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breakin...

MSP Recovery Inc trading halted, news pending

Msp Recovery, Inc. ( ($LIFW) ) has released its Q3 earnings. Here is a breakdown of the information Msp Recovery, Inc. presented to its investors. ...

MSP Recovery, Inc. Reports Q3 2024 Earnings

CACO

CVAC

DOYU

EHGO

EPOW

FFWM

FRGE

GDHG

KOSS

LIFW

LIFWW

LIFWZ

MAXN

NOAH

OPTT

PLTR

SCLX

SHPW

UCAR

UPXI

VVPR

ZCAR

Press Releases

LifeWallet Announces It Will Hold Its 2024 Annual Meeting of Stockholders at 10am ET on June 26, 2024

MSP Recovery Law Firm Files National Class Action on Behalf of Auto Dealers and Consumers Against CDK Global Over Data Breaches at More Than 15,000 Auto Dealerships

Legal

LifeWallet Announces New Comprehensive Settlement with a Group of Affiliated Property & Casualty Insurers and Completion of First Version of LifeWallet's Clearinghouse System Through its Exclusive Healthcare Partnership with Palantir Technologies

LifeWallet Announces a New Pharmaceutical Antitrust Settlement Totaling $3.1 Million

Contracts

LifeWallet Launches Initiative to Secure New Agreements with Health Plans, Providers, Insurers and Attorneys, Continues Cost Cutting Efforts, and Announces it Secured a Waiver of Acceleration Based on a Negative Going Concern from its Largest Creditor

LifeWallet Acquires Assignment of Additional MSP Claims with an Overall Paid Amount Exceeding $10.6 billion Comprised of Over 450,000 Medicare Members and Announces it Secured a Waiver of Acceleration on a Second Loan Agreement in the Event of a Negative Going Concern

LifeWallet Announces New Comprehensive Settlements Totaling More Than $5.9 Million, Continued Progress in Recoveries on Owned Claims and Acquiring Rights to Additional Claims, and Initiatives to Eliminate Wasteful Medicare Spending by Launching Beta Testing of Its Clearinghouse Solution, Built in Partnership with Palantir Technologies, Inc.

LifeWallet Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement

LifeWallet Announces Third Quarter 2024 Financial Results

LifeWallet Announces a $2 Million Pharmaceutical Litigation Settlement and Ongoing Settlement Negotiations with Multiple P&C Insurers, Pharmaceutical and Medical Device Manufacturers, While Advancing Efforts to Combat Systemic Medicare Waste, Which Aligns With Initiatives of the Newly-Formed Department of Government Efficiency (DOGE)

Comments

MSP Recovery

ニュース

最新ニュース MSP Recovery (NASDAQ:LIFW) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル